Inventor
HE CHUNHONG
US75 patents
⚠️ This page may combine multiple inventors who share the name “HE CHUNHONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INCYTE CORP
42 patentsUS7767675B2Aug 3, 2010
Imidazotriazines and imidazopyrimidines as kinase inhibitors
INCYTE CORP85 citations99
US10450313B2Oct 22, 2019
Bicyclic heterocycles as FGFR inhibitors
INCYTE CORP32 citations98
US10131667B2Nov 20, 2018
Substituted tricyclic compounds as FGFR inhibitors
INCYTE CORP35 citations98
US10040790B2Aug 7, 2018
Bicyclic heterocycles as FGFR inhibitors
INCYTE CORP36 citations98
US9611267B2Apr 4, 2017
Substituted tricyclic compounds as FGFR inhibitors
INCYTE CORP54 citations98
US9533954B2Jan 3, 2017
Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
INCYTE CORP42 citations98
US9533984B2Jan 3, 2017
Bicyclic heterocycles as FGFR inhibitors
INCYTE CORP42 citations98
US7776874B2Aug 17, 2010
Amido compounds and their use as pharmaceuticals
INCYTE CORP27 citations96
US7304081B2Dec 4, 2007
Amido compounds and their use as pharmaceuticals
INCYTE CORP42 citations96
US11053246B2Jul 6, 2021
Substituted tricyclic compounds as FGFR inhibitors
INCYTE CORP23 citations94
US10813930B2Oct 27, 2020
Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
INCYTE CORP27 citations94
US10213427B2Feb 26, 2019
Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
INCYTE CORP34 citations94
US10174030B2Jan 8, 2019
Cyclopropylamines as LSD1 inhibitors
INCYTE CORP14 citations94
US10092570B2Oct 9, 2018
Heterocyclylamines as PI3K inhibitors
INCYTE CORP17 citations94
US9981975B2May 29, 2018
Pyrrolotriazine compounds as tam inhibitors
INCYTE CORP18 citations94
US9944647B2Apr 17, 2018
Heterocyclic compounds as LSD1 inhibitors
INCYTE CORP30 citations94
US9745311B2Aug 29, 2017
Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
INCYTE CORP45 citations94
US9730939B2Aug 15, 2017
Heterocyclylamines as PI3K inhibitors
INCYTE CORP23 citations94
US9695180B2Jul 4, 2017
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
INCYTE CORP24 citations94
US9695168B2Jul 4, 2017
Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors
INCYTE CORP27 citations94
US9670210B2Jun 6, 2017
Cyclopropylamines as LSD1 inhibitors
INCYTE CORP23 citations94
US9527835B2Dec 27, 2016
Cyclopropylamines as LSD1 inhibitors
INCYTE CORP25 citations94
US9493442B2Nov 15, 2016
Cyclopropylamines as LSD1 inhibitors
INCYTE CORP30 citations94
US9493450B2Nov 15, 2016
Cyclopropylamines as LSD1 inhibitors
INCYTE CORP26 citations94
US9388185B2Jul 12, 2016
Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
INCYTE CORP44 citations94
US9221824B2Dec 29, 2015
Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors
INCYTE CORP14 citations93
US10053465B2Aug 21, 2018
Pyrrolopyrimidine derivatives as TAM inhibitors
INCYTE CORP16 citations92
US11840534B2Dec 12, 2023
Substituted tricyclic compounds as FGFR inhibitors
INCYTE CORP4 citations86
US11591338B2Feb 28, 2023
Pyrrolotriazine compounds as TAM inhibitors
INCYTE CORP5 citations86
US11530214B2Dec 20, 2022
Bicyclic heterocycles as FGFR inhibitors
INCYTE CORP7 citations86
US10300051B2May 28, 2019
Cyclopropylamines as LSD1 inhibitors
INCYTE CORP14 citations86
US11433071B2Sep 6, 2022
Heterocyclylamines as PI3K inhibitors
INCYTE CORP3 citations84
US11136326B2Oct 5, 2021
Pyrrolopyrimidine derivatives as TAM inhibitors
INCYTE CORP6 citations84
US10844069B2Nov 24, 2020
Pyrrolotriazine compounds as TAM inhibitors
INCYTE CORP9 citations84
US10800779B2Oct 13, 2020
Heterocyclic compounds as LSD1 inhibitors
INCYTE CORP6 citations84
US10717737B2Jul 21, 2020
Cyclopropylamines as LSD1 inhibitors
INCYTE CORP7 citations84
US10640503B2May 5, 2020
Imidazopyridines and imidazopyrazines as LSD1 inhibitors
INCYTE CORP7 citations84
US10556908B2Feb 11, 2020
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
INCYTE CORP8 citations84
US10442810B2Oct 15, 2019
Pyrrolotriazine compounds as TAM inhibitors
INCYTE CORP12 citations84
US10112950B2Oct 30, 2018
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
INCYTE CORP15 citations84
US9957229B2May 1, 2018
Amido compounds and their use as pharmaceuticals
INCYTE CORP4 citations84
US11673894B2Jun 13, 2023
Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors
INCYTE CORP4 citations74
YAO WENQING
3 patentsUS8754114B2Jun 17, 2014
Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
YAO WENQING49 citations98
US9126927B2Sep 8, 2015
Amido compounds and their use as pharmaceuticals
YAO WENQING20 citations92
US8058288B2Nov 15, 2011
Amido compounds and their use as pharmaceuticals
YAO WENQING22 citations92
INCYTE HOLDINGS CORP
3 patentsUS9944645B2Apr 17, 2018
Imidazotriazines and imidazopyrimidines as kinase inhibitors
INCYTE HOLDINGS CORP15 citations92
US10472367B2Nov 12, 2019
Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors
INCYTE HOLDINGS CORP5 citations84
US9988387B2Jun 5, 2018
Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors
INCYTE HOLDINGS CORP9 citations84
ZHUO JINCONG
2 patentsShowing the top 50 of 75 patents by PatentIndex Score.